joe rogan bpc-157 huberman bpc 157 with Matt Damon on Peptides in the UFC #benaffleck #joerogan #jre joe rogan bpc 157 – Peptides: What they are and

Understanding the Master Antioxidant To understand the relationship between glutathione and alcohol, we must first define what this compound does

Several factors contribute to this growing interest: Expansion of GLP-1 receptor research Development of dual- and triple-receptor agonists Increased collaboration between universities and biotechnology companies Growing publication of peer-reviewed metabolic studies Advances in peptide manufacturing and analytical testing The result is an increasingly diverse pipeline of peptides with different receptor profiles and potential research applications

AOD-9604 Pharmacokinetics & Metabolism Absorption & Distribution AOD-9604 exhibits unusual pharmacokinetic properties for a peptide, demonstrating activity via multiple administration routes in preclinical models: Oral bioavailability confirmed in pig and rodent studies, an uncommon characteristic for peptide compounds Rapid systemic distribution following intraperitoneal administration in mice (15-30 minutes) Following IV administration in pigs, AOD-9604 and degradation fragments appeared rapidly in plasma Oral administration showed slower kinetics but similar degradation product profiles Distribution studies using radiolabeled peptide (C-14-AOD9604) in rats revealed: Elevated concentrations in pineal body and thyroid tissues Distribution to all non-CNS tissues examined Minimal penetration of blood-brain barrier Tissue-specific accumulation patterns suggesting potential targeting mechanisms Metabolism & Elimination The metabolic fate of AOD-9604 involves rapid degradation through sequential N-terminal amino acid removal,: Plasma half-life of approximately 3 minutes following IV administration in pigs (compared to 21 minutes for full-length growth hormone) Sequential amino-terminal truncation represents the primary degradation pathway Principal metabolites identified in vivo include -2 amino acid and -3 amino acid fragments These truncated fragments retain some reduced in vitro anti-lipogenic activity A significant pharmacokinetic paradox exists: despite rapid plasma clearance (peptide undetectable at 56 minutes in spiked plasma studies), biological effects on body weight and fat metabolism persist for hours to days

This depends on the dose and vial size: 50mg vial at 1mg/dose = 50 doses 50mg vial at 2mg/dose = 25 doses 100mg vial at 1mg/dose = 100 doses 100mg vial at 2mg/dose = 50 doses 200mg vial at 2mg/dose = 100 doses Community-reported protocols using 1-2mg daily document a 50mg vial lasting 25-50 days